epi-2021-0077 Supplementary Tables 1–8 & Supplementary Figures 1–4

Supplementary table 1: <b>Extended clinocopathological information of donors.</b> Supplementary table 2: <b>Primers sequences for qPCR analyses.</b> Supplementary table 3: <b>Geomean of</b> <b>raw CT values of </b><b>reference genes beta-actin (<i>βactin),</i> Glyceraldehyde 3-phosphate dehydrogenase (<i>GAPDH</i>) and Succinate Dehydrogenase Complex Flavoprotein Subunit A (<i>SDHA) </i>for each donor and each tissue included in the gene-expression analysis</b><b>.</b> Supplementary table 4: <b>Associations between potential confounding variables sex, age, PMD, pH, Braak-score for gene-expression data.</b> Supplementary figure 1: <b>QQ plot of the p-values from discovery EWAS. </b> Supplementary table 5: <b>Results of the linear mixed-effects model of DNA methylation and the interaction term.</b> Supplementary table 6: <b>Mean methylation values.</b> Methylation values per DMR of SCZ and CTR samples, separated for grey and white matter. Supplementary figure 2: <b>Genome information of the four DMRs of interest.</b> Supplementary table 7: <b>Outcome variables for gene-expression data.</b> Supplementary figure 3: <b>Association </b><b>between gene expression and DMR methylation in grey and white matter of the GFM and GTS in SCZ and CTR.</b> Supplementary figure 4: <b>Principal component analysis of the DMR methylation changes</b>. Supplementary table 8: <b>Overlap with CPGs or DMRs in previous genome-wide DNA methylation studies of SCZ.</b><br>